(R)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid, 95.0%, 250mg

2-(3-BROMO-4-METHOXY-PHENYL)-PROPAN-2-OL, 90.0%, 5g

N-(4-Chloropyridin-2-yl)acetamide, 95.0%, 500mg

(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone, 98.0%, 100mg

Azepan-4-ol hydrochloride, 95.0%, 5g

m-cresol, min. 99%, for synthesis, 1 l, glass packaging

5,10,15,20-Tetra(4-pyridyl)-21H,23H-porphine, 97%, 1g

5-Amino-2-cyanobenzotrifluoride, 98.0%, 500g

5-(acetylamino)-1-phenyl-1H-pyrazole-4-carboxylic acid, 95.0%, 500mg

4-Oxo-4-((5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid, 97.0%, 250mg

3-((Tert-butoxycarbonyl)amino)-3-(4-(methylthio)phenyl)propanoic acid, 97%, 500mg

3-Bromothiophenol, 98.0%, 1g

DTT / TG12 [Dithiothreitol + alpha-Thioglycerol] (1:2 mixture) [Matrix for FABMS and liquid SIMS]1g